InSilicoTrials Awarded 2023 Innovation Radar Prize Established by European Commission in AI and Smart Devices Category
MILAN, Nov. 16, 2023 /PRNewswire/ -- InSilicoTrials (IST), a pioneering innovator in the field of clinical trials and healthcare technology, has been awarded the prestigious 2023 Innovation Radar Prize in the AI and Smart Devices category.
- MILAN, Nov. 16, 2023 /PRNewswire/ -- InSilicoTrials (IST), a pioneering innovator in the field of clinical trials and healthcare technology, has been awarded the prestigious 2023 Innovation Radar Prize in the AI and Smart Devices category.
- This recognition comes as a testament to IST's commitment to revolutionize drug and medical device development by harnessing the power of in silico technology.
- The Innovation Radar Prize, initiated by the European Commission in 2015, celebrates innovators who have received EU funding and are working to transition their innovations from the laboratory to the market.
- InSilicoTrials is honored to accept the 2023 Innovation Radar Prize in the AI and Smart Devices category and extends our gratitude to the European Commission, HaDEA, and our partners for acknowledging the significance of our work in reshaping the landscape of medical research and patient care.